Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region (XANTUS-EL)

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: February 25, 2013
Last updated: July 25, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)